Nephros Inc is a public company that specializes in developing and commercializing innovative medical technologies focused on improving the quality of life for patients with chronic kidney disease and other related health conditions. The company’s primary offerings include advanced filtration systems designed for use in dialysis and other critical care environments, as well as products aimed at enhancing water purification systems in clinical settings. By leveraging their proprietary technologies and a commitment to advancing nephrology care, Nephros aims to address the significant challenges faced by both healthcare providers and patients dealing with kidney-related disorders. Read More
SOUTH ORANGE, NJ - April 30, 2025 (NEWMEDIAWIRE) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Thursday, May 08, 2025 after market close and will host a conference call that same day at 4:30pm ET.
